L-696,474, A NOVEL CYTOCHALASIN AS AN INHIBITOR OF HIV-1 PROTEASE .3. BIOLOGICAL-ACTIVITY

被引:51
作者
LINGHAM, RB
HSU, A
SILVERMAN, KC
BILLS, GF
DOMBROWSKI, A
GOLDMAN, ME
DARKE, PL
HUANG, L
KOCH, G
ONDEYKA, JG
GOETZ, MA
机构
[1] Merck Sharp and Dohme Research Laboratories, Rahway
[2] West Point
关键词
D O I
10.7164/antibiotics.45.686
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
L-696,474, an inhibitor of the HIV-1 protease, was discovered in extracts of the fungal culture Hypoxylon fragiforme (MF551 1; ATCC 20995). L-696,474 is a novel cytochalasin with a molecular weight of 477 and an empirical formula of C30H39NO4. L-696,474 inhibited HIV-1 protease activity with an IC50 of 3-mu-M and the mode of inhibition was competitive with respect to substrate (apparent K(i) = 1-mu-M). Furthermore, L-696,474 was not a slow-binding inhibitor. The inhibition due to L-696,474 was also independent of the HIV-1 protease concentration. L-696,474 was inactive against pepsin, another aspartyl protease; stromelysin, a zinc-metalloproteinase; papain, a cysteine-specific protease or human leucocyte elastase, a serine-specific protease. Two other novel cytochalasins (L-697,318 and L-696,475) isolated from the same culture were inactive against the HIV-1 protease. Commercially available cytochalasins B, C, D, E, F, H and J were inactive while cytochalasin A was as active as L-696,474 against the HIV-1 protease.
引用
收藏
页码:686 / 691
页数:6
相关论文
共 15 条
[1]  
ACKERMANN WW, 1949, P SOC EXP BIOL MED, V72, P1
[2]  
BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535
[3]  
DARKE PL, 1989, J BIOL CHEM, V264, P2307
[4]   HIV-1 PROTEASE SPECIFICITY OF PEPTIDE CLEAVAGE IS SUFFICIENT FOR PROCESSING OF GAG AND POL POLYPROTEINS [J].
DARKE, PL ;
NUTT, RF ;
BRADY, SF ;
GARSKY, VM ;
CICCARONE, TM ;
LEU, CT ;
LUMMA, PK ;
FREIDINGER, RM ;
VEBER, DF ;
SIGAL, IS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 156 (01) :297-303
[5]   HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE - A TARGET FOR AIDS THERAPY [J].
DEBOUCK, C ;
METCALF, BW .
DRUG DEVELOPMENT RESEARCH, 1990, 21 (01) :1-17
[6]  
DIIANNI CL, 1990, J BIOL CHEM, V265, P17348
[7]   L-696,474, A NOVEL CYTOCHALASIN AS AN INHIBITOR OF HIV-1 PROTEASE .1. THE PRODUCING ORGANISM AND ITS FERMENTATION [J].
DOMBROWSKI, AW ;
BILLS, GF ;
SABNIS, G ;
KOUPAL, LR ;
MEYER, R ;
ONDEYKA, JG ;
GIACOBBE, RA ;
MONAGHAN, RL ;
LINGHAM, RB .
JOURNAL OF ANTIBIOTICS, 1992, 45 (05) :671-678
[8]   AFFINITY PURIFICATION OF THE HIV-1 PROTEASE [J].
HEIMBACH, JC ;
GARSKY, VM ;
MICHELSON, SR ;
DIXON, RAF ;
SIGAL, IS ;
DARKE, PL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 164 (03) :955-960
[9]   INHIBITION OF RETROVIRAL PROTEASE ACTIVITY BY AN ASPARTYL PROTEINASE-INHIBITOR [J].
KATOH, I ;
YASUNAGA, T ;
IKAWA, Y ;
YOSHINAKA, Y .
NATURE, 1987, 329 (6140) :654-656
[10]   VIRAL PROTEINASES - WEAKNESS IN STRENGTH [J].
KAY, J ;
DUNN, BM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1048 (01) :1-18